Dipeptidyl peptidase IV is a glycoprotein which removes N-terminal dipeptides from physiologically relevant polypeptides.
An homologous series of 6-imino-2-thioxo-5-{[3,4,5-tris(methyloxy)phenyl]methyl}-2,5-dihydro-4(3H)-pyrimidinones has been tested for inhibition of DPP IV activity. The inhibitory effects at 0.1 mM were observed. Enzyme
kinetic studies revealed that compounds inhibit DPP IV activity competitively. According to the molecular docking analysis,
the inhibitors are anchored into the DPP IV hydrolytic site by interactions of the pyrimidinone core with Glu206, Tyr662,
and Tyr547, with the alkyl chain entering the S1 pocket. We conclude that pyrimidinone-like compounds are a promising new
scaffold for reversible inhibition of DPP IV.
Keywords DPP IV inhibitor – Pyrimidinone – Enzyme kinetics – Molecular docking – Cytotoxicity
Dubravko Jelić and Donatella Verbanac equally contributed to this work.